Aryl ureas as kinase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 213/79 (2006.01) A61K 31/44 (2006.01) A61P 11/00 (2006.01) A61P 19/00 (2006.01) A61P 25/00 (2006.01) A61P 29/00 (2006.01) C07D 213/81 (2006.01) C07D 213/89 (2006.01)

Patent

CA 2475818

This invention relates to new aryl ureas of formula (I) and methods for their synthesis. The compounds are useful in the treatment of (i) raf mediated diseases, for example, cancer, (ii) p38 mediated diseases such as inflammation and osteoporosis, and (iii) VEGF mediated diseases such as angiogenesis disorders.

L'invention concerne des aryle-urées de formule (I) ainsi que des procédés destinés à les synthétiser. Ces composés sont utiles dans le traitement (i) de maladies à médiation raf, par exemple le cancer, (ii) de maladies à médiation p38 telles que l'ostéoporose et les affections inflammatoires, et (iii) de maladies à médiation VEGF telles que les troubles de l'angiogénèse.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Aryl ureas as kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aryl ureas as kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl ureas as kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1916295

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.